Moleculera Biosciences Physician Testimonials
Dr. Gary Kaplan (Part 1)
“The Panel becomes crucial in my workup of these patients to find out how much of an autoimmune process I’ve got going on.”
Watch physicians discuss how the Autoimmune Brain Panel (formerly the Cunningham Panel™)
helped in diagnosing and treating patients with immune-mediated neuropsychiatric disorders.
INVESTOR INQUIRIES
Join Moleculera Biosciences in our mission to improve the lives of those suffering from immune-mediated neuropsychiatric, cardiovascular and neurodegenerative disorders.
Investor inquiries please contact:
Craig Shimasaki, PhD, MBA President and CEO, Moleculera Biosciences shimasakic@moleculera.com
Gary Gentges Investor and Business Relations Consultant gentgesg@moleculera.com
If you would like us to contact you directly, please complete the form.